BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.33 +0.09 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $1.63 | |||
| Open | $3.23 | 52 Week Low | $0.71 | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 68,578 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.33 +0.09 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $1.63 | |||
| Open | $3.23 | 52 Week Low | $0.71 | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 68,578 | |||||

